TUCSON, Ariz., – HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for NGS-based molecular profiling applications, today announced the appointment of Suzanne Hill as Vice President of North American Capital Sales. In this role, Ms. Hill will be responsible for leading the sales team in the commercialization of the HTG EdgeSeq system […]
San Carlos, CA, – NuGEN Technologies, Inc. announced the appointment of Nitin Sood as Chief Executive Officer. He succeeds Elizabeth Hutt who recently left to pursue another opportunity. Mr. Sood comes to NuGEN from PerkinElmer, where he served as Vice President and General Manager of their life science instruments business spanning a portfolio of products […]
Omicia, Inc., a leading provider of clinical genome interpretation and reporting software, announced the completion of a $23 million Series B financing round. Several new investors participated in the round, including UPMC Enterprises, Roche Venture Fund, LDV Partners, Ping An Ventures, and a large genomics investor, as well as existing investors ARTIS Ventures, Acadia Woods […]
ST. LOUIS – Appistry, a leading provider of solutions that simplify the analysis of next-generation sequencing (NGS) data, announced that it has entered into a partnership with Washington University in St. Louis. Appistry will integrate the VarScan software, developed at the university’s McDonnell Genome Institute, for variant detection in massively parallel sequencing data with the […]
BARCELONA, Spain – QIAGEN announced two milestones in its delivery of solutions for clinical analysis and interpretation of hereditary diseases with whole exome and genome data. Widely enabling GATK best practices without technical or bioinformatics skills Beginning this month, pipeline scripts that implement the Broad Institute’s GATK best practices — a widely-used solution for variant […]
SAN DIEGO – Edico Genome, creator of the world’s first bio-IT processor designed to analyze next-generation sequencing (NGS) data, announced a third, foundational patent issued by the United States Patent and Trademark Office. U.S. patent number 14/948372, entitled “Bioinformatics Systems, Apparatuses, And Methods Executed On An Integrated Circuit Processing Platform,” broadly covers the technology and […]
PLEASANTON, Calif., – 10x Genomics, a company focused on improving and broadening the application of genomic information, announced global commercial availability of their new Chromium™ System, a transformative upgrade for the predominant generation of short-read sequencers with the ability to unlock critical long-range genomic and cell-by-cell gene expression information. “Global availability of our new Chromium […]
SOUTH SAN FRANCISCO, Calif., May 16 2016 – Fluidigm Corporation (NASDAQ:FLDM) announced the introduction of Single-Cell TCR Sequencing, a new immunology application on the C1™ system that enables in-depth profiling of T cells at single-cell resolution. Uncovering the unique T cell receptor (TCR) alpha and beta chains from each cell in conjunction with the corresponding […]
FREMONT, Calif. and MOUNTAIN VIEW, Calif., – WaferGen Bio-systems, Inc. (NASDAQ: WGBS), a publicly held genomics technology company (“WaferGen”), and Takara Bio USA Holdings, Inc. (“TBUSH”), today announced that they have entered into a merger agreement pursuant to which TBUSH will acquire WaferGen. TBUSH is a wholly owned subsidiary of Takara Bio Inc. (TSE: 4974), […]
Cambridge, UK, – Horizon Discovery Group plc (LSE: HZD) (“Horizon”), the world leader in the application of gene editing technologies, today announces it has entered into two Original Equipment Manufacture (OEM) agreements with a global market leading Next Generation Sequencing (NGS) platform company, with the potential for additional agreements to follow. Horizon is a leading […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
